ROBERT C FERRIS
Accountancy in Pittsburgh, PA
License number
Pennsylvania CA014670L
Category
Accountancy
Type
Certified Public Accountant
Address
Address
Pittsburgh, PA 15228
Professional information
Robert Ferris, Pittsburgh PA
Work:
Eye & Ear Institute
200 Lothrop St, Pittsburgh, PA 15213 University of Pittsburgh
203 Lothrop St, Pittsburgh, PA 15213
200 Lothrop St, Pittsburgh, PA 15213 University of Pittsburgh
203 Lothrop St, Pittsburgh, PA 15213
Robert Louis Ferris, Pittsburgh PA
Specialties:
Ear, Nose & Throat Doctor
Address:
200 Lothrop St, Pittsburgh, PA 15213
5117 Centre Ave, Pittsburgh, PA 15213
5117 Centre Ave, Pittsburgh, PA 15213
Board certifications:
American Board of Otolaryngology Certification in Otolaryngology
Dr. Robert L Ferris, Pittsburgh PA - MD (Doctor of Medicine)
Specialties:
Ear, Nose, and Throat
Address:
Univ Pittsbrg Phys ENT Specs
203 Lothrop St STE 300, Pittsburgh 15213
(412) 647-2100 (Phone)
203 Lothrop St STE 300, Pittsburgh 15213
(412) 647-2100 (Phone)
Languages:
English
Education:
Medical School
Johns Hopkins University / School of Medicine
Graduated: 1994
Johns Hopkins University / School of Medicine
Graduated: 1994
Cytotoxic T Cell Defined Egfr Peptide And An Optimized Derivative Peptide
US Patent:
8367069, Feb 5, 2013
Filed:
Dec 2, 2010
Appl. No.:
12/959073
Inventors:
Robert L. Ferris - Pittsburgh PA, US
Pedro Andrade - Pittsburgh PA, US
Andres Lopez-Albaitero - Pittsburgh PA, US
Pedro Andrade - Pittsburgh PA, US
Andres Lopez-Albaitero - Pittsburgh PA, US
Assignee:
University of Pittsburgh—of the Commonwealth System of Higher Education - Pittsburgh PA
International Classification:
C07K 11/00, A61K 39/39, A61K 38/08, A61K 39/12, C07K 14/71
US Classification:
4241851, 514 193, 514 216, 514939, 530328, 4241841, 4242041, 4242771, 423556, 423303
Abstract:
The invention provides a polypeptide having a sequence of amino acids consisting of IXDFGLAKL (SEQ ID NO: 1), as well as a nucleic acid encoding the polypeptide, vector comprising the nucleic acid, cell comprising the vector, and compositions thereof. The invention also provides a method of inducing a T-cell response in a patient with epithelial cancer, and a method inhibiting epithelial cancer, wherein the methods comprise administering the composition of the invention. The invention further provides a method of stimulating a cell with the inventive polypeptide and a cell so stimulated.